tm
Seeing Is Believing
tm
Seeing Is Believing
Prometheus Biosciences's activity chart (see below) currently has 84 price targets and 76 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.22% with an average time for these price targets to be met of 263.18 days.
Most recent stock forecast was given by from UBS on 10-May-2023. First documented stock forecast 22-Jun-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2023
$160
$-39.92 (-19.97%)
$160
3 years 4 months 1 days ago
(10-May-2023)
1/2 (50%)
$-34.16 (-17.59%)
52
Hold Since 10-May-2023
$200
$0.08 (0.04%)
$140
3 years 4 months 1 days ago
(10-May-2023)
4/6 (66.67%)
$5.84 (3.01%)
44
Buy Since 26-Apr-2021
$200
$0.08 (0.04%)
$139
3 years 4 months 24 days ago
(18-Apr-2023)
6/7 (85.71%)
$6.5 (3.36%)
118
Buy Since 10-Jun-2022
$138
$-61.92 (-30.97%)
3 years 4 months 24 days ago
(18-Apr-2023)
2/3 (66.67%)
$-55.5 (-28.68%)
93
Buy Since 06-Apr-2021
$200
$0.08 (0.04%)
$225
3 years 4 months 25 days ago
(17-Apr-2023)
2/4 (50%)
$6.49 (3.35%)
202
What is RXDX (Prometheus Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on RXDX (Prometheus Biosciences)?
Which analyst has the most public recommendations on RXDX (Prometheus Biosciences)?
Which analyst is the currently most bullish on RXDX (Prometheus Biosciences)?
Which analyst is the currently most reserved on RXDX (Prometheus Biosciences)?
